About the Lab

The Translational Neuroimmunology Laboratory of Charles L. Howe, Ph.D., focuses on understanding and therapeutically manipulating immunological responses to injury, loss of homeostasis, degeneration, autoimmunity and infection in the central nervous system, with the goal of protecting neurons, axons and neural circuits.

The lab's long-term research goal is to develop novel therapeutic strategies to protect and repair the central nervous system. To achieve this goal, Dr. Howe's research team manipulates and modulates the immune response and targets the injury pathways and dyshomeostatic responses induced by neuroinflammation.

The key element of functional recovery after neurological insult in children and adults is preservation and protection of axons and normalization of synaptic connections and neural circuits. Loss of axons and synapses means loss of information transfer through the neural axis and failure to maintain motor, sensory or cognitive function.

The lab uses a unique repertoire of tools, therapeutic agents and model systems to identify and characterize cells, molecules and signals that are involved in shaping the inflammatory environment in the central nervous system during neurological insult.

Tools utilized include high-resolution 4-D microscopy, flow cytometry, longitudinal immunophenotyping, EEG, behavioral analyses, reporter mice that are genetically deficient in specific chemokine receptors, and mice that are genetically engineered to express neo-antigens and novel T cell receptors. New directions in the lab include the production and interrogation of human stem cell-derived neurons and glia and analysis of patient-specific immune effectors.

If physicians can preserve even a subset of axons and synaptic connections during chronic demyelination, inflammation, tissue remodeling, scarring and healing, or during the immediate aftermath of seizures, spinal cord injury, trauma or stroke, then the patient will maintain a base for restorative, regenerative and prosthetic interventions and other therapeutic strategies aimed at renormalizing neurological structure and function.